Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis.

COVID-19 fatigue follow-up functional capacity long-term effects lung function persistent symptoms quality of life respiratory symptoms

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
27 Jul 2021
Historique:
received: 07 07 2021
revised: 21 07 2021
accepted: 23 07 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 28 8 2021
Statut: epublish

Résumé

The long-term impact of COVID-19 is still unknown. This study aimed to explore post COVID-19 effects on patients chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, health-related quality of life (HRQoL), and the ability to return to work beyond 3 months post infection. A systematic search was performed on PubMed, Web of Science, and Ovid MEDLINE on 22 May 2021, to identify studies that reported persistent effects of COVID-19 beyond 3 months follow-up. Data on the proportion of patients who had the outcome were collected and analyzed using a one-group meta-analysis. Data were extracted from 24 articles that presented information on a total of 5323 adults, post-infection, between 3 to 6 months after symptom onset or hospital discharge. The pooled prevalence of CT abnormalities was 59% (95% CI 44-73, I Post-COVID-19 patients may experience persistent respiratory symptoms, fatigue, decreased functional capacity and decreased quality of life up to 6 months after infection. Further studies are needed to establish the extent to which post-COVID-19 effects continue beyond 6 months, how they interact with each other, and to clarify their causes and their effective management.

Sections du résumé

BACKGROUND BACKGROUND
The long-term impact of COVID-19 is still unknown. This study aimed to explore post COVID-19 effects on patients chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, health-related quality of life (HRQoL), and the ability to return to work beyond 3 months post infection.
METHODS METHODS
A systematic search was performed on PubMed, Web of Science, and Ovid MEDLINE on 22 May 2021, to identify studies that reported persistent effects of COVID-19 beyond 3 months follow-up. Data on the proportion of patients who had the outcome were collected and analyzed using a one-group meta-analysis.
RESULTS RESULTS
Data were extracted from 24 articles that presented information on a total of 5323 adults, post-infection, between 3 to 6 months after symptom onset or hospital discharge. The pooled prevalence of CT abnormalities was 59% (95% CI 44-73, I
CONCLUSION CONCLUSIONS
Post-COVID-19 patients may experience persistent respiratory symptoms, fatigue, decreased functional capacity and decreased quality of life up to 6 months after infection. Further studies are needed to establish the extent to which post-COVID-19 effects continue beyond 6 months, how they interact with each other, and to clarify their causes and their effective management.

Identifiants

pubmed: 34440104
pii: biomedicines9080900
doi: 10.3390/biomedicines9080900
pmc: PMC8389585
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Eur Respir J. 2021 Feb 11;:
pubmed: 33574080
Ulster Med J. 2011 May;80(2):84-90
pubmed: 22347750
Chest. 2005 Oct;128(4):2247-61
pubmed: 16236881
Clin Infect Dis. 2020 Nov 21;:
pubmed: 33220049
Chest. 2005 Jun;127(6):2119-24
pubmed: 15947329
J Korean Med Sci. 2020 Dec 07;35(47):e418
pubmed: 33289374
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33303539
Curr Opin Crit Care. 2018 Feb;24(1):35-40
pubmed: 29189296
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
PeerJ. 2021 Apr 6;9:e11026
pubmed: 33868804
PLoS One. 2015 Jul 28;10(7):e0133698
pubmed: 26218647
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211009410
pubmed: 33878961
Lung. 2021 Apr;199(2):113-119
pubmed: 33569660
Can Respir J. 2021 Feb 13;2021:6692409
pubmed: 33628349
Chest. 2012 Sep;142(3):583-592
pubmed: 22948576
New Sci. 2020 Apr 18;246(3278):10-11
pubmed: 32372811
Eur J Phys Rehabil Med. 2021 Apr;57(2):199-207
pubmed: 33565741
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa420
pubmed: 33117851
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Thorax. 2005 May;60(5):401-9
pubmed: 15860716
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33303540
PLoS One. 2020 Dec 11;15(12):e0243882
pubmed: 33306721
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
BMC Geriatr. 2021 Mar 22;21(1):199
pubmed: 33752614
Radiographics. 2007 Mar-Apr;27(2):391-408
pubmed: 17374860
Eur J Cardiothorac Surg. 2017 Nov 1;52(5):969-974
pubmed: 28520857
EClinicalMedicine. 2020 Feb 19;20:100282
pubmed: 32300739
JAMA Netw Open. 2021 Jan 4;4(1):e2036142
pubmed: 33502487
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
Respir Med. 2020 Nov - Dec;174:106197
pubmed: 33120193
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Presse Med. 2011 Dec;40(12 Pt 2):e595-603
pubmed: 22078086
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
Emerg Radiol. 2020 Dec;27(6):711-719
pubmed: 33165674
Radiology. 2021 Apr;299(1):E177-E186
pubmed: 33497317
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33419891
Chest. 2005 Sep;128(3):1393-400
pubmed: 16162734
Clin Infect Dis. 2021 Aug 2;73(3):e826-e829
pubmed: 33624010
Eur Respir J. 2020 Nov 26;56(5):
pubmed: 33008936
Intensive Care Med. 2000 Sep;26(9):1304-11
pubmed: 11089757
Thorax. 2021 Apr;76(4):402-404
pubmed: 33273023
ERJ Open Res. 2021 Feb 08;7(1):
pubmed: 33575312
Ann Am Thorac Soc. 2021 Apr 19;:
pubmed: 33872135
Eur Radiol. 2001;11(12):2436-43
pubmed: 11734936
Respir Res. 2020 Jun 29;21(1):163
pubmed: 32600344
Tuber Lung Dis. 1994 Apr;75(2):116-26
pubmed: 8032044
Clin Med (Lond). 2021 Jan;21(1):e63-e67
pubmed: 33243837

Auteurs

Diana C Sanchez-Ramirez (DC)

Department of Respiratory Therapy, College of Rehabilitation Sciences, University of Manitoba, Winnipeg, MB R3E 0T6, Canada.

Kaylene Normand (K)

Department of Respiratory Therapy, College of Rehabilitation Sciences, University of Manitoba, Winnipeg, MB R3E 0T6, Canada.

Yang Zhaoyun (Y)

School of Nursing, Jilin University, Changchun 130012, China.

Rodrigo Torres-Castro (R)

Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago 8320000, Chile.

Classifications MeSH